Zhejiang Huahai Pharmaceutical News

Huahai Pharmaceutical (600521): Leading pharmaceutical manufacturing enterprises go overseas and welcome growth domestically

招商證券Feb 27 00:00

Huahai Pharmaceutical (600521): Short-term APIs and domestic formulations are under pressure, optimistic that preparations will go overseas

中金公司Jan 26 14:11

Huahai Pharmaceutical (600521): The two-wheel drive business for APIs and formulations is progressing steadily

中金公司Oct 31, 2023 00:00

Huahai Pharmaceutical (600521): Steady performance and rapid growth in formulation business

財通證券Sep 1, 2023 00:00

Huahai Pharmaceutical (600521): Performance is in line with expectations to promote the internationalization of formulations

中金公司Aug 31, 2023 08:22

Huahai Pharmaceutical (600521): The advantages of API integration help high performance growth, outstanding R&D innovation highlights

方正證券May 3, 2023 00:00

Huahai Pharmaceutical (600521): The 2022 performance is in line with expectations, and the pharmaceutical business is developing rapidly

中金公司May 3, 2023 00:00

Huahai Pharmaceutical (600521): Dual wheel drive performance can be expected, increased innovation is expected to open up space

財通證券Feb 10, 2023 11:11

Huahai Pharmaceutical (600521): Signed a VV116 production agreement and operations continued to rise

中金公司Feb 1, 2023 13:26

Huahai Pharmaceutical (600521): Performance is in line with expectations and the inflection point of recovery throughout the year is clear

東吳證券Nov 1, 2022 00:00

Huahai Pharmaceutical (600521): Internationalization of advanced pharmaceutical manufacturing leaders opens up room for growth

中金公司Oct 10, 2022 09:36

Huahai Pharmaceutical (600521): the company's performance enters the high growth channel and the growth momentum is expected to be further strengthened in the medium term.

華創證券Aug 31, 2022 17:11

Huahai Pharmaceutical (600521) 2022 Annual report performance Forecast comments: the overall improvement of the three major business sectors led the company's quarterly and semi-annual performance to an all-time high

華創證券Jul 14, 2022 10:21

Huahai Pharmaceutical Co., Ltd. (600521): Yueming Pharmaceutical Advanced Manufacturing Leader set sail again

華創證券May 22, 2022 13:11

Huahai Pharmaceutical (600521): Growth momentum is still strong, equity incentives are inspiring

光大證券May 5, 2021 00:00

Comments on Huahai Pharmaceutical (600521) Annual report 2020 and Quarterly report 2021: high performance growth Equity incentive demonstrates the Company's confidence

東吳證券Apr 28, 2021 00:00

Comments on Huahai Pharmaceutical (600521) 2020 Annual report and 2021 Quarterly report: note the new increment and new momentum of forward integration

浙商證券Apr 26, 2021 00:00

Huahai Pharmaceutical Co., Ltd. (600521): short-term fluctuation and medium-term catalysis

浙商證券Apr 10, 2021 00:00

Huahai Pharmaceutical (600521): Time and space for leading pharmaceutical exporters to grow

浙商證券Nov 12, 2020 00:00

Huahai Pharmaceutical Co., Ltd. (600521) Quarterly report 2020 comments: performance exceeded expectations of preparation and API business volume

西南證券Oct 31, 2020 00:00